257 related articles for article (PubMed ID: 25872462)
1. Circulating endothelial progenitor cells and angiogenic factors in diabetes complicated diabetic foot and without foot complications.
Kulwas A; Drela E; Jundziłł W; Góralczyk B; Ruszkowska-Ciastek B; Rość D
J Diabetes Complications; 2015 Jul; 29(5):686-90. PubMed ID: 25872462
[TBL] [Abstract][Full Text] [Related]
2. VEGF-A and PDGF-BB--angiogenic factors and the stage of diabetic foot syndrome advancement.
Drela E; Kulwas A; Jundziłł W; Góralczyk B; Boinska J; Drewniak W; Gadomska G; Rość D
Endokrynol Pol; 2014; 65(4):306-12. PubMed ID: 25185854
[TBL] [Abstract][Full Text] [Related]
3. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
[TBL] [Abstract][Full Text] [Related]
4. Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts.
Massot A; Navarro-Sobrino M; Penalba A; Arenillas JF; Giralt D; Ribó M; Molina CA; Alvarez-Sabín J; Montaner J; Rosell A
Cerebrovasc Dis; 2013; 35(1):81-8. PubMed ID: 23429001
[TBL] [Abstract][Full Text] [Related]
5. Poor outcome of experimental ischemic stroke in type 2 diabetic rats: impaired circulating endothelial progenitor cells mobilization.
Yang H; Ma S; Liu Y; Li Y; Wu W; Han E; Jia G; Wang C
J Stroke Cerebrovasc Dis; 2015 May; 24(5):980-7. PubMed ID: 25813059
[TBL] [Abstract][Full Text] [Related]
6. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Lee IG; Chae SL; Kim JC
Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke.
Xue L; Chen H; Zhang T; Chen J; Geng Z; Zhao Y
Metab Brain Dis; 2017 Apr; 32(2):641-648. PubMed ID: 28093678
[TBL] [Abstract][Full Text] [Related]
8. Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy.
Motawi TK; Rizk SM; Ibrahim IA; El-Emady YF
Cell Biochem Funct; 2014 Mar; 32(2):155-63. PubMed ID: 23913471
[TBL] [Abstract][Full Text] [Related]
9. Attenuated endothelial function is associated with decreased endothelial progenitor cells and nitric oxide in premenopausal diabetic women.
Liu J; Hu DJ; Yan H; Liu J; Ai X; Ren Z; Zeng H; He H; Yang Z
Mol Med Rep; 2018 Nov; 18(5):4666-4674. PubMed ID: 30221702
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of circulating endothelial progenitor cells and related angiogenic markers as prognostic factors in soft-tissue tumors.
Karampinis I; Joas E; Dreyer A; Ronellenfitsch U; Jakob J; Hohenberger P; Nowak K
Eur J Surg Oncol; 2018 Apr; 44(4):496-501. PubMed ID: 29397265
[TBL] [Abstract][Full Text] [Related]
11. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
[TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cells and peripheral neuropathy in subjects with type 2 diabetes mellitus.
Eleftheriadou I; Dimitrakopoulou N; Kafasi N; Tentolouris A; Dimitrakopoulou A; Anastasiou IA; Mourouzis I; Jude E; Tentolouris N
J Diabetes Complications; 2020 Apr; 34(4):107517. PubMed ID: 31928893
[TBL] [Abstract][Full Text] [Related]
13. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis.
Grisar J; Aletaha D; Steiner CW; Kapral T; Steiner S; Seidinger D; Weigel G; Schwarzinger I; Wolozcszuk W; Steiner G; Smolen JS
Circulation; 2005 Jan; 111(2):204-11. PubMed ID: 15642766
[TBL] [Abstract][Full Text] [Related]
14. Endothelial progenitor cells in diabetic foot syndrome.
Drela E; Stankowska K; Kulwas A; Rość D
Adv Clin Exp Med; 2012; 21(2):249-54. PubMed ID: 23214290
[TBL] [Abstract][Full Text] [Related]
15. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, soluble fatty acid synthase, and adrenomedullin in diabetic retinopathy.
Zakareia FA; Alderees AA; Al Regaiy KA; Alrouq FA
J Diabetes Complications; 2010; 24(3):179-85. PubMed ID: 19216096
[TBL] [Abstract][Full Text] [Related]
16. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
18. Study of the association of adrenomedullin and basic-fibroblast growth factors with the peripheral arterial blood flow and endothelial dysfunction biomarkers in type 2 diabetic patients with peripheral vascular insufficiency.
Alrouq FA; Al-Masri AA; Al-Dokhi LM; Alregaiey KA; Bayoumy NM; Zakareia FA
J Biomed Sci; 2014 Oct; 21(1):94. PubMed ID: 25287126
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-210 in the peripheral blood of patients with newly diagnosed type 2 diabetes mellitus and its effect on the number and function of endothelial progenitor cells.
Li X; Jia Z; Zhao X; Xu M; Chen M
Microvasc Res; 2020 Sep; 131():104032. PubMed ID: 32533960
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
J Infect; 2017 Jan; 74(1):10-21. PubMed ID: 27717783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
